학술논문

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors
Document Type
Article
Source
In: Cancers. (Cancers, January 2024, 16(1))
Subject
Language
English
ISSN
20726694